===============================================================================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. _)*
REPLIDYNE, INC.
(Name of Issuer)
COMMON STOCK, PAR VALUE $0.001 PER SHARE
(Title of Class of Securities)
76028W107
(CUSIP Number)
DECEMBER 31, 2006
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this
Schedule is filed:
[_] Rule 13d-1(b)
[_] Rule 13d-1(c)
[X] Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities,
and for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the reminder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
===============================================================================
CUSIP NO. 76028W107 Schedule 13G Page 2 of 24
--------------------------------------------------------------------------------
1. Name of Reporting Person Perseus-Soros BioPharmaceutical Fund, LP
S.S. or I.R.S. Identifica-
tion No. of Above Person
--------------------------------------------------------------------------------
2. Check the Appropriate Box (a) [_]
if a Member of a Group (b) [X]
--------------------------------------------------------------------------------
3. S.E.C. Use Only
--------------------------------------------------------------------------------
4. Citizenship or Place of Organization Delaware
--------------------------------------------------------------------------------
Number of Shares (5) Sole Voting Power 1,368,382
Beneficially (6) Shared Voting Power 0
Owned by Each (7) Sole Dispositive Power 1,368,382
Reporting Person (8) Shared Dispositive Power 0
--------------------------------------------------------------------------------
9. Aggregate Amount Beneficially Owned by Each Reporting Person
1,368,382
--------------------------------------------------------------------------------
10. Check if the Aggregate Amount in Row (9) Excludes Certain
Shares
[_]
--------------------------------------------------------------------------------
11. Percent of Class Represented by Amount in Row 9 5.1%
--------------------------------------------------------------------------------
12. Type of Reporting Person PN
--------------------------------------------------------------------------------
CUSIP NO. 76028W107 Schedule 13G Page 3 of 24
--------------------------------------------------------------------------------
1. Name of Reporting Person Perseus-Soros Partners, LLC
S.S. or I.R.S. Identifica-
tion No. of Above Person
--------------------------------------------------------------------------------
2. Check the Appropriate Box (a) [_]
if a Member of a Group (b) [X]
--------------------------------------------------------------------------------
3. S.E.C. Use Only
--------------------------------------------------------------------------------
4. Citizenship or Place of Organization Delaware
--------------------------------------------------------------------------------
Number of Shares (5) Sole Voting Power 1,368,382
Beneficially (6) Shared Voting Power 0
Owned by Each (7) Sole Dispositive Power 1,368,382
Reporting Person (8) Shared Dispositive Power 0
--------------------------------------------------------------------------------
9. Aggregate Amount Beneficially Owned by Each Reporting Person
1,368,382
--------------------------------------------------------------------------------
10. Check if the Aggregate Amount in Row (9) Excludes Certain
Shares
[_]
--------------------------------------------------------------------------------
11. Percent of Class Represented by Amount in Row 9 5.1%
--------------------------------------------------------------------------------
12. Type of Reporting Person OO
--------------------------------------------------------------------------------
CUSIP NO. 76028W107 Schedule 13G Page 4 of 24
--------------------------------------------------------------------------------
1. Name of Reporting Person Perseus BioTech Fund Partners, LLC
S.S. or I.R.S. Identifica-
tion No. of Above Person
--------------------------------------------------------------------------------
2. Check the Appropriate Box (a) [_]
if a Member of a Group (b) [X]
--------------------------------------------------------------------------------
3. S.E.C. Use Only
--------------------------------------------------------------------------------
4. Citizenship or Place of Organization Delaware
--------------------------------------------------------------------------------
Number of Shares (5) Sole Voting Power 0
Beneficially (6) Shared Voting Power 1,368,382
Owned by Each (7) Sole Dispositive Power 0
Reporting Person (8) Shared Dispositive Power 1,368,382
--------------------------------------------------------------------------------
9. Aggregate Amount Beneficially Owned by Each Reporting Person
1,368,382
--------------------------------------------------------------------------------
10. Check if the Aggregate Amount in Row (9) Excludes Certain
Shares
[_]
--------------------------------------------------------------------------------
11. Percent of Class Represented by Amount in Row 9 5.1%
--------------------------------------------------------------------------------
12. Type of Reporting Person OO
--------------------------------------------------------------------------------
CUSIP NO. 76028W107 Schedule 13G Page 5 of 24
--------------------------------------------------------------------------------
1. Name of Reporting Person SFM Participation, L.P.
S.S. or I.R.S. Identifica-
tion No. of Above Person
--------------------------------------------------------------------------------
2. Check the Appropriate Box (a) [_]
if a Member of a Group (b) [X]
--------------------------------------------------------------------------------
3. S.E.C. Use Only
--------------------------------------------------------------------------------
4. Citizenship or Place of Organization Delaware
--------------------------------------------------------------------------------
Number of Shares (5) Sole Voting Power 0
Beneficially (6) Shared Voting Power 1,368,382
Owned by Each (7) Sole Dispositive Power 0
Reporting Person (8) Shared Dispositive Power 1,368,382
--------------------------------------------------------------------------------
9. Aggregate Amount Beneficially Owned by Each Reporting Person
1,368,382
--------------------------------------------------------------------------------
10. Check if the Aggregate Amount in Row (9) Excludes Certain
Shares
[_]
--------------------------------------------------------------------------------
11. Percent of Class Represented by Amount in Row 9 5.1%
--------------------------------------------------------------------------------
12. Type of Reporting Person PN
--------------------------------------------------------------------------------
CUSIP NO. 76028W107 Schedule 13G Page 6 of 24
--------------------------------------------------------------------------------
1. Name of Reporting Person SFM AH LLC
S.S. or I.R.S. Identifica-
tion No. of Above Person
--------------------------------------------------------------------------------
2. Check the Appropriate Box (a) [_]
if a Member of a Group (b) [X]
--------------------------------------------------------------------------------
3. S.E.C. Use Only
--------------------------------------------------------------------------------
4. Citizenship or Place of Organization Delaware
--------------------------------------------------------------------------------
Number of Shares (5) Sole Voting Power 0
Beneficially (6) Shared Voting Power 1,368,382
Owned by Each (7) Sole Dispositive Power 0
Reporting Person (8) Shared Dispositive Power 1,368,382
--------------------------------------------------------------------------------
9. Aggregate Amount Beneficially Owned by Each Reporting Person
1,368,382
--------------------------------------------------------------------------------
10. Check if the Aggregate Amount in Row (9) Excludes Certain
Shares
[_]
--------------------------------------------------------------------------------
11. Percent of Class Represented by Amount in Row 9 5.1%
--------------------------------------------------------------------------------
12. Type of Reporting Person OO
--------------------------------------------------------------------------------
CUSIP NO. 76028W107 Schedule 13G Page 7 of 24
--------------------------------------------------------------------------------
1. Name of Reporting Person Perseuspur, LLC
S.S. or I.R.S. Identifica-
tion No. of Above Person
--------------------------------------------------------------------------------
2. Check the Appropriate Box (a) [_]
if a Member of a Group (b) [X]
--------------------------------------------------------------------------------
3. S.E.C. Use Only
--------------------------------------------------------------------------------
4. Citizenship or Place of Organization Delaware
--------------------------------------------------------------------------------
Number of Shares (5) Sole Voting Power 0
Beneficially (6) Shared Voting Power 1,368,382
Owned by Each (7) Sole Dispositive Power 0
Reporting Person (8) Shared Dispositive Power 1,368,382
--------------------------------------------------------------------------------
9. Aggregate Amount Beneficially Owned by Each Reporting Person
1,368,382
--------------------------------------------------------------------------------
10. Check if the Aggregate Amount in Row (9) Excludes Certain
Shares
[_]
--------------------------------------------------------------------------------
11. Percent of Class Represented by Amount in Row 9 5.1%
--------------------------------------------------------------------------------
12. Type of Reporting Person OO
--------------------------------------------------------------------------------
CUSIP NO. 76028W107 Schedule 13G Page 8 of 24
--------------------------------------------------------------------------------
1. Name of Reporting Person Frank H. Pearl
S.S. or I.R.S. Identifica- (in the capacity described herein)
tion No. of Above Person
--------------------------------------------------------------------------------
2. Check the Appropriate Box (a) [_]
if a Member of a Group (b) [X]
--------------------------------------------------------------------------------
3. S.E.C. Use Only
--------------------------------------------------------------------------------
4. Citizenship or Place of Organization United States
--------------------------------------------------------------------------------
Number of Shares (5) Sole Voting Power 0
Beneficially (6) Shared Voting Power 1,384,695*
Owned by Each (7) Sole Dispositive Power 0
Reporting Person (8) Shared Dispositive Power 1,384,695*
--------------------------------------------------------------------------------
9. Aggregate Amount Beneficially Owned by Each Reporting Person
1,384,695*
--------------------------------------------------------------------------------
10. Check if the Aggregate Amount in Row (9) Excludes Certain
Shares
[_]
--------------------------------------------------------------------------------
11. Percent of Class Represented by Amount in Row 9 5.1%*
--------------------------------------------------------------------------------
12. Type of Reporting Person IN
--------------------------------------------------------------------------------
* Includes 16,313 shares of common stock issuable upon the exercise of stock
options. The stock options are held for the benefit of an entity controlled by
affiliates of the Perseus-Soros BioPharmaceutical Fund, LP.
CUSIP NO. 76028W107 Schedule 13G Page 9 of 24
--------------------------------------------------------------------------------
1. Name of Reporting Person George Soros
S.S. or I.R.S. Identifica- (in the capacity described herein)
tion No. of Above Person
--------------------------------------------------------------------------------
2. Check the Appropriate Box (a) [_]
if a Member of a Group (b) [X]
--------------------------------------------------------------------------------
3. S.E.C. Use Only
--------------------------------------------------------------------------------
4. Citizenship or Place of Organization United States
--------------------------------------------------------------------------------
Number of Shares (5) Sole Voting Power 0
Beneficially (6) Shared Voting Power 1,384,695*
Owned by Each (7) Sole Dispositive Power 0
Reporting Person (8) Shared Dispositive Power 1,384,695*
--------------------------------------------------------------------------------
9. Aggregate Amount Beneficially Owned by Each Reporting Person
1,384,695*
--------------------------------------------------------------------------------
10. Check if the Aggregate Amount in Row (9) Excludes Certain
Shares
[_]
--------------------------------------------------------------------------------
11. Percent of Class Represented by Amount in Row 9 5.1%*
--------------------------------------------------------------------------------
12. Type of Reporting Person IA
--------------------------------------------------------------------------------
* Includes 16,313 shares of common stock issuable upon the exercise of stock
options. The stock options are held for the benefit of an entity controlled by
affiliates of the Perseus-Soros BioPharmaceutical Fund, LP.
CUSIP NO. 76028W107 Schedule 13G Page 10 of 24
--------------------------------------------------------------------------------
1. Name of Reporting Person Soros Fund Management LLC
S.S. or I.R.S. Identifica-
tion No. of Above Person
--------------------------------------------------------------------------------
2. Check the Appropriate Box (a) [_]
if a Member of a Group (b) [X]
--------------------------------------------------------------------------------
3. S.E.C. Use Only
--------------------------------------------------------------------------------
4. Citizenship or Place of Organization Delaware
--------------------------------------------------------------------------------
Number of Shares (5) Sole Voting Power 0
Beneficially (6) Shared Voting Power 1,384,695*
Owned by Each (7) Sole Dispositive Power 0
Reporting Person (8) Shared Dispositive Power 1,384,695*
--------------------------------------------------------------------------------
9. Aggregate Amount Beneficially Owned by Each Reporting Person
1,384,695*
--------------------------------------------------------------------------------
10. Check if the Aggregate Amount in Row (9) Excludes Certain
Shares
[_]
--------------------------------------------------------------------------------
11. Percent of Class Represented by Amount in Row 9 5.1%*
--------------------------------------------------------------------------------
12. Type of Reporting Person OO; IA
--------------------------------------------------------------------------------
* Includes 16,313 shares of common stock issuable upon the exercise of stock
options. The stock options are held for the benefit of an entity controlled by
affiliates of the Perseus-Soros BioPharmaceutical Fund, LP.
CUSIP NO. 76028W107 Schedule 13G Page 11 of 24
Item 1. (a) NAME OF ISSUER
Replidyne, Inc. (the "Company").
(b) ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES
1450 Infinite Drive
Louisville, CO 80027
Item 2. (a) NAMES OF PERSONS FILING
This Statement is being filed on behalf of each of
the following persons (collectively, the "Reporting
Persons")
(i) Perseus-Soros BioPharmaceutical Fund, LP, a
Delaware limited partnership ("Perseus-Soros");
(ii) Perseus-Soros Partners, LLC, a Delaware limited
liability company ("PSP GP" and general partner of
Perseus-Soros);
(iii) Perseus BioTech Fund Partners, LLC, a Delaware
limited liability company ("PBFP Partners" and
managing member of PSP GP);
(iv) SFM Participation, L.P., a Delaware limited
partnership ("SFM Participation" and managing
member of PSP GP);
(v) SFM AH LLC, a Delaware limited liability company
("SFM AH" and general partner of SFM
Participation);
(vi) Perseuspur, LLC, a Delaware limited liability
company ("Perseuspur" and managing member of PBFP
Partners);
(vii) Mr. Frank H. Pearl ("Mr. Pearl" and sole member of
Perseuspur);
(viii) Mr. George Soros ("Mr. Soros" and Chairman of SFM
LLC); and
(ix) Soros Fund Management LLC, a Delaware limited
liability company ("SFM LLC" and the sole managing
member of SFM AH).
CUSIP NO. 76028W107 Schedule 13G Page 12 of 24
(b) ADDRESS OF PRINCIPAL BUSINESS OFFICE
The address of the principal business offices of (i)
Perseus-Soros and (ii) PSP, GP is 888 Seventh Avenue, 30th
Floor, New York, NY 10106.
The address of the principal business offices of (i) PBFP
Partners, (ii) Perseuspur and (iii) Mr. Pearl is 2099
Pennsylvania Ave., N.W., Suite 900, Washington, D.C.
20006.
The address of the principal business offices of (i) SFM
Participation, (ii) SFM AH, (iii) SFM LLC and (iv) Mr.
Soros is 888 Seventh Avenue, 33rd Floor, New York, NY
10106.
(c) CITIZENSHIP
(i) Perseus-Soros - a Delaware limited partnership
(ii) PSP GP - a Delaware limited liability company
(iii) PBFP Partners - a Delaware limited liability company
(iv) SFM Participation - a Delaware limited partnership
(v) SFM AH - a Delaware limited liability company
(vi) Perseuspur - Delaware limited liability company
(vii) Mr. Pearl - United States
(viii) Mr. Soros - United States
(ix) SFM LLC - a Delaware limited liability company
(d) TITLE OF CLASS OF SECURITIES
Common Stock, par value $0.001 per share (the "Common
Stock" or "Shares")
(e) CUSIP NUMBER
76028W107
Information contained herein concerning SFM Participation,
SFM AH, SFM LLC and Mr. Soros has been provided by SFM
LLC. Perseus-Soros, PSP GP, PBFP Partners, Perseuspur and
Mr. Pearl assume no responsibility for such information.
Information contained herein concerning PBFP Partners,
Perseuspur and Mr. Pearl has been provided by each such
Reporting Person. Perseus-Soros, PSP GP, SFM
Participation, SFM AH, SFM LLC and Mr. Soros assume no
responsibility for such information.
CUSIP NO. 76028W107 Schedule 13G Page 13 of 24
Item 3. This statement is not being filed pursuant to either Rule
13d-1(b) or 13d-2(b) or (c).
Item 4. OWNERSHIP.
(a) AMOUNT BENEFICIALLY OWNED:
Each of the Reporting Persons other than Mr. Soros, Mr.
Pearl and SFM LLC may be deemed to beneficially own
1,368,382 Shares.
Each of Mr. Soros, Mr. Pearl and SFM LLC may be deemed to
beneficially own an aggregate of 1,384,695 Shares,
including 16,313 shares of common stock issuable upon the
exercise of stock options. The stock options are held for
the benefit of an entity controlled by affiliates of the
Perseus-Soros BioPharmaceutical Fund, LP.
(b) PERCENTAGE OWNED:
Based on calculations made in accordance with Rule
13d-3(d), and there being 26,935,680 Shares outstanding as
of October 31, 2006, each of the Reporting Persons may be
deemed to beneficially own approximately 5.1% of the
outstanding Common Stock.
(c) NUMBER OF SHARES AS TO WHICH SUCH PERSON HAS:
(i) Each of Perseus-Soros and PSP GP may be deemed to have
sole power to direct the voting and disposition of the
1,368,382 Shares beneficially owned by Perseus-Soros.
(ii) By virtue of the relationships between and among the
Reporting Persons as described in Item 2, each of:
(a) PBFP Partners, Perseuspur, SFM Participation and SFM
AH may be deemed to share the power to direct the voting
and disposition of 1,368,382 Shares beneficially owned by
Perseus-Soros and (b) each of Mr. Soros, Mr. Pearl and SFM
LLC may be deemed to share the power to direct the voting
and disposition of the 1,368,382 Shares beneficially owned
by Perseus-Soros, and the 16,313 Shares issuable upon the
exercise of stock options. The stock options are held for
the benefit of an entity controlled by affiliates of the
Perseus-Soros BioPharmaceutical Fund, LP.
Item 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS
Not applicable.
Item 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON
The partners of Perseus-Soros have the right to participate in
the receipt of dividends from, or proceeds from the sale of, the
CUSIP NO. 76028W107 Schedule 13G Page 14 of 24
securities held for the account of Perseus-Soros in accordance
with their ownership interests in Perseus-Soros.
Item 7. IDENTIFICATION AND CLASSIFICATION OF SUBSIDIARY WHICH ACQUIRED
THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY
Not applicable.
Item 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP
Not applicable.
Item 9. NOTICE OF DISSOLUTION OF GROUP
Not applicable.
Item 10. CERTIFICATION
Not applicable.
[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]
CUSIP NO. 76028W107 Schedule 13G Page 15 of 24
SIGNATURES
After reasonable inquiry and to the best of our knowledge and
belief, the undersigned certify that the information set forth in this
statement is true, complete and correct.
Dated as of February 13, 2007
PERSEUS-SOROS BIOPHARMACEUTICAL FUND, LP
By: Perseus-Soros Partners, LLC
General Partner
By: SFM Participation, L.P.
Managing Member
By: SFM AH LLC
General Partner
By: Soros Fund Management LLC
Managing Member
By: /s/ Jodye M. Anzalotta
--------------------------------------
Name: Jodye M. Anzalotta
Title: Assistant General Counsel
CUSIP NO. 76028W107 Schedule 13G Page 16 of 24
PERSEUS-SOROS PARTNERS, LLC
By: SFM Participation, L.P.
Managing Member
By: SFM AH LLC
General Partner
By: Soros Fund Management LLC
Managing Member
By: /s/ Jodye M. Anzalotta
--------------------------------------
Name: Jodye M. Anzalotta
Title: Assistant General Counsel
PERSEUS BIOTECH FUND PARTNERS, LLC
By: Perseuspur, LLC
Member
By: /s/ Rodd Macklin
---------------------------------------
Name: Rodd Macklin
Title: Secretary and Treasurer
CUSIP NO. 76028W107 Schedule 13G Page 17 of 24
SFM PARTICIPATION, L.P.
By: SFM AH LLC
General Partner
By: Soros Fund Management LLC
Managing Member
By: /s/ Jodye M. Anzalotta
--------------------------------------
Name: Jodye M. Anzalotta
Title: Assistant General Counsel
SFM AH LLC
By: Soros Fund Management LLC
Managing Member
By: /s/ Jodye M. Anzalotta
--------------------------------------
Name: Jodye M. Anzalotta
Title: Assistant General Counsel
PERSEUSPUR, LLC
By: /s/ Rodd Macklin
---------------------------------------
Name: Rodd Macklin
Title: Secretary and Treasurer
CUSIP NO. 76028W107 Schedule 13G Page 18 of 24
MR. FRANK H. PEARL
By: /s/ Rodd Macklin
---------------------------------------
Name: Rodd Macklin
Title: Attorney-in-Fact
MR. GEORGE SOROS
By: /s/ Jodye M. Anzalotta
----------------------------------------
Name: Jodye M. Anzalotta
Title: Attorney-in-Fact
SOROS FUND MANAGEMENT LLC
By: /s/ Jodye M. Anzalotta
--------------------------------------
Name: Jodye M. Anzalotta
Title: Assistant General Counsel
CUSIP NO. 76028W107 Schedule 13G Page 19 of 24
EXHIBIT INDEX
-------------
Exhibit 1. Joint Filing Agreement as required by Rule 13d-1(k)(1) under
the Securities Exchange Act of 1934, as amended.
Exhibit 2. Power of Attorney, dated June 16, 2005 appointing each of
Armando T. Belly, Jodye Anzalotta, Maryann Canfield, Jay
Schoenfarber and Robert Soros as Attorney-In-Fact for George
Soros.
Exhibit 3. Power of Attorney, dated April 9, 2003, appointing Rodd
Macklin as Attorney-in-Fact for Frank H. Pearl.
CUSIP NO. 76028W107 Schedule 13G Page 20 of 24
EXHIBIT 1
JOINT FILING AGREEMENT PURSUANT TO RULE 13d-1(k)(1)
The undersigned acknowledge and agree that the foregoing
statement on Schedule 13G is filed on behalf of each of the undersigned and
that all subsequent amendments to this statement on Schedule 13G shall be filed
on behalf of each of the undersigned without the necessity of filing additional
joint filing statements. The undersigned acknowledge that each shall be
responsible for the timely filing of such amendments, and for the completeness
and accuracy of the information concerning him, her or it contained herein, but
shall not be responsible for the completeness and accuracy of the information
concerning the other entities or persons, except to the extent that he, she or
it knows or has reason to believe that such information is inaccurate.
Dated as of February 13, 2007
PERSEUS-SOROS BIOPHARMACEUTICAL FUND, LP
By: Perseus-Soros Partners, LLC
General Partner
By: SFM Participation, L.P.
Managing Member
By: SFM AH LLC
General Partner
By: Soros Fund Management LLC
Managing Member
By: /s/ Jodye M. Anzalotta
--------------------------------------
Name: Jodye M. Anzalotta
Title: Assistant General Counsel
CUSIP NO. 76028W107 Schedule 13G Page 21 of 24
PERSEUS-SOROS PARTNERS, LLC
By: SFM Participation, L.P.
Managing Member
By: SFM AH LLC
General Partner
By: Soros Fund Management LLC
Managing Member
By: /s/ Jodye M. Anzalotta
--------------------------------------
Name: Jodye M. Anzalotta
Title: Assistant General Counsel
PERSEUS BIOTECH FUND PARTNERS, LLC
By: Perseuspur, LLC
Member
By: /s/ Rodd Macklin
---------------------------------------
Name: Rodd Macklin
Title: Secretary and Treasurer
SFM PARTICIPATION, L.P.
By: SFM AH LLC
General Partner
By: Soros Fund Management LLC
Managing Member
By: /s/ Jodye M. Anzalotta
--------------------------------------
Name: Jodye M. Anzalotta
Title: Assistant General Counsel
CUSIP NO. 76028W107 Schedule 13G Page 22 of 24
SFM AH LLC
By: Soros Fund Management LLC
Managing Member
By: /s/ Jodye M. Anzalotta
--------------------------------------
Name: Jodye M. Anzalotta
Title: Assistant General Counsel
PERSEUSPUR, LLC
By: /s/ Rodd Macklin
---------------------------------------
Name: Rodd Macklin
Title: Secretary and Treasurer
MR. FRANK H. PEARL
By: /s/ Rodd Macklin
---------------------------------------
Name: Rodd Macklin
Title: Attorney-in-Fact
MR. GEORGE SOROS
By: /s/ Jodye M. Anzalotta
----------------------------------------
Name: Jodye M. Anzalotta
Title: Attorney-in-Fact
SOROS FUND MANAGEMENT LLC
By: /s/ Jodye M. Anzalotta
--------------------------------------
Name: Jodye M. Anzalotta
Title: Assistant General Counsel
CUSIP NO. 76028W107 Schedule 13G Page 23 of 24
EXHIBIT 2
POWER OF ATTORNEY
KNOW ALL MEN BY THESE PRESENT, that I, GEORGE SOROS, hereby make, constitute
and appoint each of ARMANDO T. BELLY, JODYE ANZALOTTA, MARYANN CANFIELD, JAY
SCHOENFARBER and ROBERT SOROS, acting individually, as my agent and
attorney-in-fact for the purpose of executing in my name, (a) in my personal
capacity or (b) in my capacity as Chairman of, member of or in other capacities
with Soros Fund Management LLC ("SFM LLC") and each of its affiliates or
entities advised by me or SFM LLC, all documents, certificates, instruments,
statements, filings and agreements ("documents") to be filed with or delivered
to any foreign or domestic governmental or regulatory body or required or
requested by any other person or entity pursuant to any legal or regulatory
requirement relating to the acquisition, ownership, management or disposition
of securities, futures contracts or other investments, and any other documents
relating or ancillary thereto, including without limitation all documents
relating to filings with the Commodity Futures Trading Commission and National
Futures Association, the United States Securities and Exchange Commission (the
"SEC") pursuant to the Securities Act of 1933 or the Securities Exchange Act of
1934 (the "Act") and the rules and regulations promulgated thereunder,
including all documents relating to the beneficial ownership of securities
required to be filed with the SEC pursuant to Section 13(d) or Section 16(a) of
the Act and any information statements on Form 13F required to be filed with
the SEC pursuant to Section 13(f) of the Act.
All past acts of these attorneys-in-fact in furtherance of the foregoing are
hereby ratified and confirmed.
Execution of this power of attorney revokes that certain Power of Attorney
dated as of the 11th March 2005 with respect to the same matters addressed
above.
This power of attorney shall be valid from the date hereof until revoked by me.
IN WITNESS WHEREOF, I have executed this instrument as of the 16th day of June
2005.
GEORGE SOROS
/s/ Daniel Eule
--------------------------
Name: Daniel Eule
Title: Attorney-in-Fact
CUSIP NO. 76028W107 Schedule 13G Page 24 of 24
EXHIBIT 3
POWER OF ATTORNEY
KNOW ALL BY THESE PRESENTS, that I, FRANK H. PEARL, hereby make, constitute and
appoint RODD MACKLIN as my agent and attorney-in-fact for the purpose of
executing in my name, (a) in my personal capacity or (b) in my capacity as
Chairman of, member of or in other capacities with Perseus LLC ("PERSEUS") and
each of its affiliates or entities advised by me or Perseus, all documents,
certificates, instruments, statements, filings and agreements ("DOCUMENTS") to
be filed with or delivered to any foreign or domestic governmental or
regulatory body or required or requested by any other person or entity pursuant
to any legal or regulatory requirement relating to the acquisition, ownership,
management or disposition of securities, futures contracts, or other
investments, and any other documents relating or ancillary thereto, including
but not limited to, all documents relating to filings with the Commodities
Futures Trading Commission and National Futures Association, the United States
Securities and Exchange Commission (the "SEC") pursuant to the Commodities
Exchange Act and the Securities Act of 1933 or the Securities Exchange Act of
1934 (the "Act") and the rules and regulations promulgated thereunder,
including all documents relating to the beneficial ownership of securities
required to be filed with the SEC pursuant to Section 13(d) or Section 16(a) of
the Act and information statements on Form 13F required to be filed with the
SEC pursuant to Section 13(f) of the Act.
All past acts of the attorney-in-fact in furtherance of the foregoing are
hereby ratified and confirmed.
This power of attorney shall be valid from the date hereof until revoked by me.
IN WITNESS WHEREOF, I have executed this instrument as of the 9th day of April,
2003.
/s/ Frank H. Pearl
------------------------------
FRANK H. PEARL